Interestingly, a previous study found that endogenous anti-CD38 antibodies negatively correlated with disease activity, which could indicate that endogenous anti-CD38 activity confers a protective effect in SLE [10]. This evidence concerns the gene CD38 and systemic lupus erythematosus.